ExodusPoint Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

ExodusPoint Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,944	Closed	-$1.02M	–	2862
2021 Q4	$1.02M	Buy	+10,944	New	+$721K	0.01%	1061
2021 Q3	–	Sell	-5,899	Closed	-$402K	–	2883
2021 Q2	$402K	Buy	+5,899	New	+$385K	﹤0.01%	1564

ExodusPoint Capital Management's ARNA Position: Q1 2022 in Review

ExodusPoint Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 10,944 shares — an estimated $1.02M sold.

ExodusPoint Capital Management first reported a position in ARNA in Q2 2021 and held it in 2 quarters. The position peaked at $1.02M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

ExodusPoint Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 10,944 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.02M.
ExodusPoint Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 2 quarters.
ExodusPoint Capital Management's Arena Pharmaceuticals Inc position peaked at $1.02M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.